Industry News

ILIFE Launches Its First Customer Appreciation Activity in the US

SHENZHEN, China, Sept. 17, 2021 /PRNewswire/ -- ILIFE , a leading brand of robotic vacuum cleaner, today announces its firstCustomer Appreciation Activity to show its gratitude to the US customers for more than six y...

2021-09-17 23:30 3486

Baidu-Backed DeepWay Unveils Smart New Energy Heavy-Duty Truck to Automate Road Freight

BEIJING, Sept. 17, 2021 /PRNewswire/ -- DeepWay, a Baidu-backed company, today unveiled Xingtu, a smart new energy heavy-duty truck with a computing power of more than 500 TOPS and ultra-long-distance sensing capabilities of more than 1 kilometer. This announcement marks Baidu's entry into the US...

2021-09-17 21:09 5625

China.org.cn: Election Committee subsector elections to open new chapter in HK democracy

BEIJING, Sept. 17, 2021 /PRNewswire/ -- A news report by China.org.cn on Hong Kong Election Committee subsector elections:   The results of the Legislative Assembly election of the Macao Special Administrative Region (SAR) have been released, while the 2021 Hong Kong SAR Electi...

2021-09-17 21:00 2029

Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021

SEOUL, South Korea, Sept. 17, 2021 /PRNewswire/ -- A leading medical AI provider Lunit today announced that its AI for tissue analysis has been applied in a clinical trial for drug development, accurately predicting the patients' response to immunotherapy. Including this major finding, the compan...

2021-09-17 21:00 2101

MINISO Group Files Annual Report on Form 20-F for Fiscal Year 2021

GUANGZHOU, China, Sept. 17, 2021 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO) ("MINISO", "MINISO Group" or the "Company"), a fast-growing global value retailer offering a variety of design-led lifestyle products, today filed with the U.S. Securities and Exchange Commission its annual...

2021-09-17 20:45 18383

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for First-Line Treatment of sqNSCLC Accepted by China's NMPA, Phase 3 MRCT Met its Primary Endpoint

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound ...

2021-09-17 20:00 4934

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355

BEIJING, Sept. 17, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies called Tiannuojiancheng Pharm...

2021-09-17 20:00 5913

RYB Education, Inc. Reports Second Quarter 2021 Financial Results

BEIJING, Sept. 17, 2021 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB), a leading early childhood education service provider in China, today announced its unaudited financial results for the second quarter of 2021. Second Quarter 2021 Operational and Financial Summary ...

2021-09-17 20:00 18059

RYB Education, Inc. Announces Change of Board Composition

BEIJING, Sept. 17, 2021 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB), a leading early childhood education service provider in China, today announced the resignation of Mr. Chimin Cao as the chairman of the board of directors (the "Board") of the Company and the re-desi...

2021-09-17 20:00 18066

111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that Senior Vice President, Investor Relations and...

2021-09-17 19:00 4784

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management p...

2021-09-17 18:30 2295

"Captain Tsubasa: Dream Team" Dream Championship 2021 Online Qualifiers Kick Off Today

TOKYO, Sept. 17, 2021 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that the Japanese and global versions ofCaptain Tsubasa: Dream Team will hold the worldwide Dream Championship 2021 tournament and will kick off its online qualifiers starting today. Additionally, special ...

2021-09-17 18:15 2160

Tarena to Report Second Quarter of 2021 Financial Results on September 24, 2021

BEIJING, Sept. 17, 2021 /PRNewswire/ -- Tarena International, Inc. (NASDAQ: TEDU) ("Tarena" or the "Company"), a leading provider of adult professional education and childhood and adolescent quality education services inChina, today announced that it will report its unaudited financial results fo...

2021-09-17 18:00 14982

The Joint Venture between ReneSola Power and Eiffel Investment Group Acquires Its First 200 MW Project Portfolio

STAMFORD, Conn., Sept. 17, 2021 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, today announced that European Solar Energy Development JV, the joint venture co...

2021-09-17 18:00 3622

During the Mid-autumn Festival, Guangdong Pomelo Appears on a Screen overseas

GUANGZHOU, China, Sept. 17, 2021 /PRNewswire/ -- September 21 (the fifteenth day of the eighth lunar month) is the Mid-autumn Day, a traditional Chinese festival. A poster themed "Enjoy Guangdong Pomelo, Enjoy Mid-autumn Festival" circulates on a 19.5-meter-high, 12.2-meter-wide screen at the Tim...

2021-09-17 17:18 2050

NTT-Shochiku Partners Decides to Stream Exciting "Cho Kabuki" Performance to 11 Countries

TOKYO, Sept. 17, 2021 /PRNewswire/ -- NTT-Shochiku Partners has recorded live performances of the "Cho Kabuki" stage productions at the Minamiza Theatre in Kyoto for audiences to watch on demand. The live recordings took place on September 12 (Sun.) and the on-demand service will be available from...

2021-09-17 16:00 2365

Dada Group Launches Smart Delivery SaaS System to accelerate delivery digitalization

SHANGHAI, Sept. 16, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA) ("DADA"), China's leading local on-demand delivery and retail platform, today announced the launch of its open digital logistics platform, Dada Smart Delivery SaaS System. Based on Dada Now's self-developed Smart Logistics System ...

2021-09-17 11:54 3491

The Orolay Amazon Coat Is Back with A Chic New Vision This Winter

NORTH BERGEN, N.J., Sept. 16, 2021 /PRNewswire/ -- "The Amazon Coat" has taken the internet for its warmth and stylish design. It was reported by many well-known media as well, like "New York Magazine", "People", etc.Emma Stone, Lucy Hale, Oprah and many other stars became its loyal fans in the p...

2021-09-17 09:43 2162

Arctic Vision Announces Addition of Novel Mydriatic Drug MydCombi™ (ARVN004) to Eyenovia Commercialization Deal

SHANGHAI, Sept. 16, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today that it will expand its exclusive license agreement with Eyenovia, Inc. (NASDAQ: EYEN) to include a third asset, MydCombi™, for development and commerc...

2021-09-17 08:00 2076

Bridge Biotherapeutics Presents Pre-Clinical Data of BBT-176 at the European Society for Medical Oncology (ESMO) Virtual Congress 2021

* Pre-clinical data exploring the in vitro and in vivo efficacy of BBT-176 will be disclosed via an ePoster at the ESMO Congress 2021 * Patient dosing for the phase 1/2 clinical study of BBT-176 was initiated in April 2021…the topline data of the first-in-human, dose escalation study is expec...

2021-09-17 06:00 2321